Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage…
NCT00003652 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00003652 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer |
| Official title | Intensification Therapy for Locally Advanced Epidermoid Cancer of the Anal Canal - Phase III Intergroup Study |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, fluorouracil, neoadjuvant therapy, radiation therapy |
| Enrollment | 350 |
| Start date | Jan 4, 1999 |
| Primary completion | Apr 1, 2006 |
| Completion | Mar 31, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 17, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: